Trial
NCT02007252
ACZ885 for the Treatment of Abdominal Aortic Aneurysm
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Novartis Pharmaceuticals
Collaborators
—
Condition
Abdominal Aortic Aneurysm (AAA)
Intervention
ACZ885
Why stopped
The results of a third interim analysis (ad hoc) indicated a lack of efficacy and futility in continuing the trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-01-05